Leonid Bajenov, Ph.D., M.D., a professor at the Vakhidov Research Center of Surgery, Tashkent, Republic of Uzbekistan, has published more than 300 scientific works. Dr. Bajenov is currently conducting clinical trials of Coley Fluid.

Zuhal Butuner, OD, MSc, MBA, is a clinical and regulatory advisor. Dr. Butuner was previously Senior Clinical Program Manager at Biogen Inc., where she led and managed the team responsible for obtaining FDA approval for the drug Avonex®.

Peter Coy, M.D., is a retired radiation oncologist, formerly director of the Victoria Cancer Centre and clinical assistant professor at the University of British Columbia. As chair of the lung cancer sub-committee of the National Cancer Institute of Canada Clinical Trials Committee, Dr. Coy was involved in the completion of five multi institutional clinical trials in lung cancer using combinations of surgery, radiation, chemotherapy and immunotherapy.

Hal Gunn, M.D., is a co-founder and chief executive officer of the Centre for Integrated Healing, Vancouver, BC, a non-profit organization funded in part by the Medical Services Plan of BC, the Canadian Cancer Society, and the BC Cancer Agency. Dr. Gunn has used bacterial vaccines in the treatment of cancer, and has a clinical appointment with the University of British Columbia School of Medicine.

Kenneth Wilson, M.D., is a medical oncologist at the Vancouver Island Cancer Centre and a clinical associate professor at the University of British Columbia. Dr. Wilson has published more than 150 papers and communications, and is a member of the American Society of Clinical Oncology and the Canadian Association of Medical Oncologists.